BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23469311)

  • 1. Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sickness.
    Tiberti N; Lejon V; Hainard A; Courtioux B; Robin X; Turck N; Kristensson K; Matovu E; Enyaru JC; Mumba Ngoyi D; Krishna S; Bisser S; Ndung'u JM; Büscher P; Sanchez JC
    PLoS Negl Trop Dis; 2013; 7(2):e2088. PubMed ID: 23469311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness.
    Tiberti N; Hainard A; Lejon V; Courtioux B; Matovu E; Enyaru JC; Robin X; Turck N; Kristensson K; Ngoyi DM; Vatunga GM; Krishna S; Büscher P; Bisser S; Ndung'u JM; Sanchez JC
    PLoS One; 2012; 7(7):e40909. PubMed ID: 22815865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients.
    Tiberti N; Matovu E; Hainard A; Enyaru JC; Lejon V; Robin X; Turck N; Ngoyi DM; Krishna S; Bisser S; Courtioux B; Büscher P; Kristensson K; Ndung'u JM; Sanchez JC
    Clin Transl Med; 2013 Jan; 2(1):1. PubMed ID: 23369533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis.
    Lejon V; Roger I; Mumba Ngoyi D; Menten J; Robays J; N'siesi FX; Bisser S; Boelaert M; Büscher P
    Clin Infect Dis; 2008 Jul; 47(1):15-22. PubMed ID: 18494605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics Identifies Multiple Candidate Biomarkers to Diagnose and Stage Human African Trypanosomiasis.
    Vincent IM; Daly R; Courtioux B; Cattanach AM; Biéler S; Ndung'u JM; Bisser S; Barrett MP
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005140. PubMed ID: 27941966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neopterin and CXCL-13 in Diagnosis and Follow-Up of
    Bonnet J; Vignoles P; Tiberti N; Gedeão V; Hainard A; Turck N; Josenando T; Ndung'u JM; Sanchez JC; Courtioux B; Bisser S
    Biomed Res Int; 2019; 2019():6070176. PubMed ID: 31886231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.
    Hainard A; Tiberti N; Robin X; Lejon V; Ngoyi DM; Matovu E; Enyaru JC; Fouda C; Ndung'u JM; Lisacek F; Müller M; Turck N; Sanchez JC
    PLoS Negl Trop Dis; 2009 Jun; 3(6):e459. PubMed ID: 19554086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study.
    Kande Betu Ku Mesu V; Mutombo Kalonji W; Bardonneau C; Valverde Mordt O; Ngolo Tete D; Blesson S; Simon F; Delhomme S; Bernhard S; Mahenzi Mbembo H; Mpia Moke C; Lumeya Vuvu S; Mudji E'kitiak J; Akwaso Masa F; Mukendi Ilunga M; Mpoyi Muamba Nzambi D; Mayala Malu T; Kapongo Tshilumbwa S; Botalema Bolengi F; Nkieri Matsho M; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
    Lancet Glob Health; 2021 Jul; 9(7):e999-e1008. PubMed ID: 34143998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness.
    Mumba Ngoyi D; Lejon V; Pyana P; Boelaert M; Ilunga M; Menten J; Mulunda JP; Van Nieuwenhove S; Muyembe Tamfum JJ; Büscher P
    J Infect Dis; 2010 Feb; 201(3):453-63. PubMed ID: 20047500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study.
    Deborggraeve S; Lejon V; Ekangu RA; Mumba Ngoyi D; Pati Pyana P; Ilunga M; Mulunda JP; Büscher P
    PLoS Negl Trop Dis; 2011 Feb; 5(2):e972. PubMed ID: 21364966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parasites in the brain? The search for sleeping sickness biomarkers.
    Burchmore R
    Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1283-6. PubMed ID: 23241185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid-Derived Microvesicles From Sleeping Sickness Patients Alter Protein Expression in Human Astrocytes.
    Dozio V; Lejon V; Mumba Ngoyi D; Büscher P; Sanchez JC; Tiberti N
    Front Cell Infect Microbiol; 2019; 9():391. PubMed ID: 31824868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of Trypanosoma brucei gambiense from cured and relapsed sleeping sickness patients and adaptation to laboratory mice.
    Pyana PP; Ngay Lukusa I; Mumba Ngoyi D; Van Reet N; Kaiser M; Karhemere Bin Shamamba S; Büscher P
    PLoS Negl Trop Dis; 2011 Apr; 5(4):e1025. PubMed ID: 21526217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients.
    Maclean L; Odiit M; Sternberg JM
    Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):270-5. PubMed ID: 16343570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects.
    Bonnet J; Garcia C; Leger T; Couquet MP; Vignoles P; Vatunga G; Ndung'u J; Boudot C; Bisser S; Courtioux B
    J Proteomics; 2019 Mar; 196():150-161. PubMed ID: 30414516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early prediction of treatment efficacy in second-stage gambiense human African trypanosomiasis.
    Priotto G; Chappuis F; Bastard M; Flevaud L; Etard JF
    PLoS Negl Trop Dis; 2012; 6(6):e1662. PubMed ID: 22701752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of cerebrospinal fluid from the meningo-encephalitic stage of T. b. gambiense and rhodesiense sleeping sickness patients using TMT quantitative proteomics.
    Tiberti N; Sanchez JC
    Data Brief; 2015 Sep; 4():400-5. PubMed ID: 26306311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up study.
    Ngay Lukusa I; Van Reet N; Mumba Ngoyi D; Mwamba Miaka E; Masumu J; Patient Pyana P; Mutombo W; Ngolo D; Kobo V; Akwaso F; Ilunga M; Kaninda L; Mutanda S; Mpoyi Muamba D; Valverde Mordt O; Tarral A; Rembry S; Büscher P; Lejon V
    EBioMedicine; 2022 Dec; 86():104376. PubMed ID: 36436279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study.
    Büscher P; Mertens P; Leclipteux T; Gilleman Q; Jacquet D; Mumba-Ngoyi D; Pyana PP; Boelaert M; Lejon V
    Lancet Glob Health; 2014 Jun; 2(6):e359-63. PubMed ID: 25103304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CATT negative result after treatment for human African trypanosomiasis is no indication for cure.
    Lejon V; Ngoyi DM; Boelaert M; Büscher P
    PLoS Negl Trop Dis; 2010 Jan; 4(1):e590. PubMed ID: 20126270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.